cell and gene therapy – Patient Worthy

Castle Creek Biosciences Expands Their Cell and Gene Therapy Platform By Acquiring Novavita Thera Inc.

Post author:Alyssa Stevens
Post published:January 21, 2022
Post category:Rare Disease Tyrosinemia

According to a recent article, Castle Creek Inc. has acquired Novavita Thera Inc. in an effort to expand its research and development efforts. Castle Creek Inc. Castle Creek Biosciences Inc.…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Castle Creek Biosciences Expands Their Cell and Gene Therapy Platform By Acquiring Novavita Thera Inc.

Why Your Voice in Research Matters: Groundbreaking Studies are Changing What's Possible

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

Let’s Work Together!

Keep Up to Date

Learn More